Doctors, Hospitals, Pharmacies Warned Not to Stockpile Meds
Professional societies issue stern warning not to inappropriately prescribe meds for COVID - 19
Publication date: May 2020Source: Membrane Technology, Volume 2020, Issue 5Author(s):
Conclusions: Keeping a dog at home before and during pregnancy decreased the risk of food allergy in 1-year-old children. This effect was eliminated in case of having a cat, hamster, guinea pig, or rabbit. PMID: 32489363 [PubMed]
Publication date: Available online 3 June 2020Source: Clinica Chimica ActaAuthor(s): Agostino Ognibene, Maria Lorubbio, Pasqualino Magliocca, Emanuela Tripodo, Guendalina Vaggelli, Giovanni Iannelli, Marco Feri, Raffaele Scala, Alessandro Polcini Tartaglia, Angelo Galano, Alessandro Pancrazzi, Danilo Tacconi
Publication date: Available online 4 June 2020Source: Obesity Research &Clinical PracticeAuthor(s): Diego Moriconi, Stefano Masi, Eleni Rebelos, Agostino Virdis, Maria Laura Manca, Salvatore De Marco, Stefano Taddei, Monica Nannipieri
One in 10 physicians worldwide report seeing at least one case of COVID - 19 reinfection
(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded AIDS Clinical Trials Group (ACTG). Teva Pharmaceuticals is donating medications for the study.
Shulkin, ninth secretary for Veterans Affairs, estimates health care provider revenue down about $ 500 billion
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2020 E-Newsletter In this issue: NIDCR News Funding Opportunities NIH/HHS News Funding Notices Science Advances Subscribe to NICDR News Grantee News NIDCR News CDC’s COVID-19 Guidance for Dental Settings Dental health care personnel can find COVID-19-related information on the CDC’s Division of Oral Health website, which offers guidance and resources for clinics and health care facilities and recommen...
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide appeared first on Inter Press Service.
More News: Allergy | Allergy & Immunology | Brain | Cancer & Oncology | Cardiology | COVID-19 | Dermatology | Emergency Medicine | Endocrinology | Gastroenterology | Geriatrics | Heart | HIV AIDS | Hospitals | Internal Medicine | Neurology | Nurses | Nursing | Opthalmology | Orthopaedics | Respiratory Medicine | Skin | Urology & Nephrology | Warnings